Stock DIGN DIGNITANA AB
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Dignitana AB

Equities

DIGN

SE0002108001

Market Closed - Nasdaq Stockholm
Other stock markets
 12:00:00 2024-07-05 pm EDT 		5-day change 1st Jan Change
1.54 SEK 0.00% Intraday chart for Dignitana AB +1.99% -29.36%
Jun. 24 Dignitana Deputy Chairman Resigns MT
Jun. 24 Dignitana AB Announces the Resignation of William Cronin as Deputy Chairman of the Board, Effective 24 June 2024 CI

Strengths

  • The prospective high growth for the next fiscal years is among the main assets of the company
  • The company has a low valuation given the cash flows generated by its activity.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses

  • The company does not generate enough profits, which is an alarming weak point.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • Over the past four months, analysts' average price target has been revised downwards significantly.
  • The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
DIGNITANA AB Stock Dignitana AB
-29.36% 11.83M -
SHOCKWAVE MEDICAL Stock Shockwave Medical
+75.69% 12.57B -
B-
PENUMBRA, INC. Stock Penumbra, Inc.
-28.01% 7.02B
C+
MASIMO CORPORATION Stock Masimo Corporation
-2.09% 6.09B
C-
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD. Stock Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
+10.01% 5.24B
D+
GETINGE AB Stock Getinge AB
-18.23% 4.76B
B
APT MEDICAL INC. Stock APT Medical Inc.
+15.57% 4.11B -
INARI MEDICAL, INC. Stock Inari Medical, Inc.
-20.84% 2.99B
C
SKAN GROUP AG Stock SKAN Group AG
-1.24% 2B -
NOVOCURE LIMITED Stock NovoCure Limited
+12.39% 1.81B
C-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
  1. Stock Market
  2. Equities
  3. DIGN Stock
  4. Ratings Dignitana AB